Journal of Capital Medical University ›› 2019, Vol. 40 ›› Issue (2): 263-268.doi: 10.3969/j.issn.1006-7795.2019.02.020

Previous Articles     Next Articles

Synthesis of novel mononuclear Ru(Ⅱ) complexes with 10,13-diaryl substituents on the dppz ligands

Li Minna   

  1. Department of Chemical Biology, School of Pharmaceutical Sciences, Capital Medical University, Beijing 100069, China
  • Received:2018-04-24 Online:2019-03-21 Published:2019-04-15
  • Supported by:
    This study was supported by National Natural Science Foundation for Young Scientist of China (21708027), Scientific Research Common Program of Beijing Municipal Commission of Education (SQKM201210025006), Natural Science Foundation of Capital Medical University in China (2015ZR17).

Abstract: Objective Four new ruthenium complexes with 1,10-phenanthroline ancillary ligand and 10, 13-position substituted[pyrido-(3,2-a:2',3'-c)phenazine,dppz] major ligands including thiophenyl,furanyl,[2-benzo(b)thienyl]-2,1,3-benzothiadiazole and[2-benzo(b)furanyl]-2,1,3-benzothiadiazole will be designed and synthesized. Methods Target complexes were made by condensation reaction of ruthenium complex with the appropriate 3,6-diaryl substituted benzene-1,2-diamine. The latter 3,6-diaryl substituted benzene-1,2-diamine was obtained by a Suzuki-coupling reaction, and subsequently by reduction with NaBH4 under catalysis of CoCl2. Results Benzothiadiazole intermediates and corresponding target complexes are well characterized by 1H nuclear magnetic resonance (NMR), 13C NMR and TOF-Mass. UV-vis absorption spectra of all ruthenium complexes further verify the structures of the target complexes. Conclusion In this paper, we have synthesized four mononuclear ruthenium complexes with 1,10-phenanthroline ancillary ligand and 10, 13-diaryl including thiophenyl,furanyl,[2-benzo(b)thienyl]-2,1,3-benzothiadiazole and[2-benzo(b)furanyl]-2,1,3-benzothiadiazole, substituted dppz as major ligand through multiple steps. Both four 4,7-position substituted 2,1,3-benzothiadiazole intermediates and corresponding ruthenium complexes exhibit substantially similar absorption spectra despite the structural difference.

Key words: ruthenium complexes, pyrido-(3,2-a:2',3'-c)phenazine ligand, 10,13-diaryl substituted

CLC Number: